Market Research Trending

  The growing need for purification of biopharmaceuticals is primarily fueling growth of the global prepacked chromatography columns market . Moreover, the increasing launch of biopharmaceutical drugs is again fostering the growth of the market. According to Pharmaceutical Research and Manufacturers of America, over 750 orphan drugs were approved in the U.S. in 2018, compared to over 600 in 2017. Additionally, the growing R&D of biosimilars is expected to provide potential growth opportunities. For instance, in May 2018, Pfizer, Inc., a U.S.-based pharmaceutical company, received the U.S. Food and Drug Administration (FDA) approval for RETACRIT, which is a biosimilar to Epogen and Procrit. It is the first and only FDA approved biosimilar erythropoiesis-stimulating agent. 1.       In January 2020, Agilent Technologies Inc. collaborated with the Indian Institute of Technology Delhi, India, to promote biopharmaceutical research 2.    ...

  Prepacked chromatography columns are column-like structures containing various chemical substances that are utilized as conductors. When a compound is passed through the column, these chemicals usually react chemically with one another or with any other components in the compound. The information in the chemical reaction is collected by the column's various nozzles and collected within the column's body. This information is valuable to pharmacists and other clinical scientists who need this information for experimental purposes. The prepackaged chromatography columns available for sale in the market are designed for use in various types of laboratories, including those in the pharmaceutical industry. Because of their versatility and ability to suit various purposes, these chemical-free columns have been gaining much favor in the commercial world. The processing and packaging of chromatography-based compounds have now become standard in the medical and food industries, espec...